医学
内科学
贝伐单抗
肝细胞癌
队列
回顾性队列研究
阿替唑单抗
肿瘤科
抗生素
质子抑制剂泵
队列研究
胃肠病学
化疗
癌症
彭布罗利珠单抗
免疫疗法
微生物学
生物
作者
Takeshi Hatanaka,Satoru Kakizaki,Atsushi Hiraoka,Toshifumi Tada,Masashi Hirooka,Kazuya Kariyama,Joji Tani,Masanori Atsukawa,Koichi Takaguchi,Ei Itobayashi,Shinya Fukunishi,Kunihiko Tsuji,Toru Ishikawa,Kazuto Tajiri,Hironori Ochi,Satoshi Yasuda,Hidenori Toyoda,Chikara Ogawa,Takashi Nishimura,Noritomo Shimada
摘要
The therapeutic outcomes of Atez/Bev in HCC patients did not differ between patients with and without PPI treatment or between patients with and without antibiotic treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI